Social
#RNL2021 Coverage from @KDAO2011
"Psoriatic Arthritis Pearls by Dr. E Ruderman
-MTX monoRx is effective
-which TNFi does not matter
-Secukinumab 300 mg is better than 150 mg dose
-OK to use IL-17i in pts with FHx of IBD"
#RheumNow
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
CDC updates its COVID Comorbid Dz list to include type 1 diabetes (& NIDDMA), mod-severe asthma, liver Dz, dementia , stroke/cerebrovascular disease, HIV infxn, cystic fibrosis, obesity, substance use disorders (NOT ARTHRITIS, PSORIASIS) https://t.co/LbVMVGf4IR
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years ago
Survey of 500 pts with systemic rheumatic diseases during the COVID-19 pandemic showed few who discontinuations Rx - 2.2% D/C for fear of immunosuppression; 3.8% for shortages (mostly HCQ); 2.6%) for resp infx and 6% for side-effects. https://t.co/2BJIYeBSIu
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
Hydroxychloroquine studied vs Vitamin C (PBO) prophylaxis to households (n=671) exposed to COVID-19. 89% were COVD1-9 test neg at baseline. HCQ did not protect against progression to COVID (53 vs 45 events; adj HR, 1.10 [95% CI, 0.73 to 1.66]. A vit C Win! https://t.co/S5qjdIYaXq
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
News Feature: Comparison of Three Coronavirus Vaccines
https://t.co/omxsA8W3nQ https://t.co/s7dc9NwMQo
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
News Feature: Rheumatic Patients Are at Risk for COVID Death
https://t.co/bhJG1vuVA4 https://t.co/VEN3nwSOPB
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
REMDACTA trial of Actemra plus remdesivir failed to meet its primary endpoint of improved time to hospital discharge for patients with severe COVID-19 pneumonia (nor its key secondary endpoints) compared to remdesivir alone https://t.co/OyqpnwUVXU
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
News Feature: Low Anaphylaxis Risk with COVID mRNA Vaccines
JAMA reports a safety survey of hospital employees showing that the risk of anaphylaxis from mRNA vaccines is 2.47 per 10,000 individuals.
https://t.co/hN7UWNasQo https://t.co/0UhOZuGze1
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
COVID Vaccine Rebuttals by Dr. Kathryn Dao ( @KDAO2011)
Dr. Dao addresses the common vaccine concerns that have been posed to her and her rebuttals.
https://t.co/f5gwBICEGy https://t.co/Nzm1HfY5GW
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
News Feature: Low Anaphylaxis Risk with COVID mRNA Vaccines
JAMA reports a safety survey of hospital employees showing that the risk of anaphylaxis from mRNA vaccines is 2.47 per 10,000 individuals.
https://t.co/hN7UWNasQo https://t.co/pVlaTUSCH7
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 1 month ago
